Background and aim:
Currently, the rate of hospital-acquired infections due to drug-resistant
Pseudomonas aeruginosa
strains shows an increasing trend and remains one of the principal reasons for mortalilty in burn patients. This study aimed to investigate the prevalence of genes conferring resistance to carbapenems in
P. aeruginosa
isolates from burn patients.
Methods:
A total of 50
P. aeruginosa
isolates were tested for antibiotic susceptibility and presence of multidrug-resistant (MDR) and extensively drug resistant (XDR) isolates, using phenotypic tests. Screening for genes conferring resistance to carbapenems was investigated by multiplex PCR method.
Results:
Susceptibility testing demonstrated the highest resistance against amikacin, ceftazidime (n=44/88% each), and gentamicin (84%), while colistin sulfate was the most effective antibiotic. The rate of MDR and XDR isolates was revealed as 50% and 40% respectively. We detected the following carbapenemase genes:
blaNDM
(32%), followed by
blaOXA-48
(18%), and
blaBIC-1
(14%). This study revealed a high antibiotic resistance in
P. aeruginosa
isolates with a total of 40% and 50% MDR and XDR isolates respectively, and 70% carbapenem resistance. The prevalence of carbapenem conferring genes tested among carbapenem-resistant isolates was demonstrated as 65.7%.
Conclusion:
Due to the prevalence of
P. aeroginosa
strains carrying
blaOXA-48
and
blaNDM
genes in our hospital, more attention and implementation of effective control measures against nosocomial infection are recommended.
In this work, large numbers of hydrophilic functional groups were introduced onto gelatin by grafting with N-vinyl pyrollidone monomer. The graft copolymerization reactions were carried out under nitrogen atmosphere using ammonium persulfate (APS) as an initiator. The graft copolymer was characterized by Fourier transform infrared spectra, thermo-gravimetric analysis and solubility test. The existence of a sharp intense peak at 1653 cm-1 in FTIR spectra of the graft copolymer, improvement of the thermal stability of gelatin-based copolymer and the solubility difference of the copolymer and the homopolymer prove the formation of graft copolymer. The effects of reaction variables, such as concentration of the initiator, monomer and gelatin, as well as, reaction temperature and time were investigated and the grafting conditions were optimized. The optimum reaction conditions resulting in maximum grafting ratio and add-on value have been determined.
We assessed the effect of sorafenib-loaded polyamidoamine (PAMAM) dendrimer on liver fibrosis induced by bile duct ligation (BDL). Male Wistar rats were divided into 9 groups: intact, sham, DMSO + BDL, BDL, sorafenib (30 mg/kg), sorafenib (60 mg/kg), PAMAM + BDL, sorafenib (30 mg/kg) + PAMAM + BDL, sorafenib (60 mg/kg) + PAMAM + BDL. BDL was induced and then rats were treated daily with sorafenib and (or) PAMAM for 4 weeks. Improvement of liver was detected via assessment of ascites formation, collagen deposition, liver blood flow, vascular endothelial growth factor level, and blood cells count. Sorafenib-loaded PAMAM dendrimer in both 30 and 60 mg/kg doses reduced ascites formation, reduced collagen deposition, and improved drug-induced hematological side effects of sorafenib alone in comparison with sorafenib-alone treatment. Sorafenib-loaded PAMAM dendrimer increased liver blood flow compared with sorafenib-received groups. Sorafenib-loaded PAMAM dendrimer reduced BDL-induced liver injury compared with sorafenib-received groups. Moreover, sorafenib-loaded PAMAM dendrimer decreased vascular endothelial growth factor level in serum and liver tissue in comparison with sorafenib-received groups. Sorafenib-loaded PAMAM dendrimer profoundly improved the therapeutic effects of sorafenib in BDL rats.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.